title: Drug resistance in leishmaniasis: Newer developments.
abstract: Leishmaniasis is a vector borne protozoan disease and it remains a major public health problem world-wide. Lack of an effective vaccine and vector control program makes the chemotherapy as the primary tool for leishmaniasis. Antimonials were used as the first line of treatment for many years. Emergence of resistance against this drug has become a major concern. Literatures and studies published on anti-leishmanial drug resistance, newer drug discovery for leishmanial resistance etc., in PubMed, Medline and Google search and reviewed thoroughly. Various newer drugs have been identified but, are in limited use because of high cost, toxicity, resistance etc., Recently, many newer mechanisms of drug resistance have been identified which may boost in future designing and development of drugs.
authors.affiliation: Department of Microbiology, Vardhaman Mahavir Medical College and Safdarjung Hospital, New Delhi, India.
authors.forename: Sarita
authors.initials: S
authors.lastname: Mohapatra
keywords: Amphotericin B; antimonials; drug resistance; leishmaniasis; miltefocine; paromomycin
references.citation: Am J Trop Med Hyg. 2005 Dec;73(6):1005-11
references.pmid: 16354802
references.citation: Trans R Soc Trop Med Hyg. 2000 Mar-Apr;94(2):200-4
references.pmid: 10897369
references.citation: Indian J Med Res. 2006 Mar;123(3):411-22
references.pmid: 16778320
references.citation: J Pharm Pharmacol. 1998 Dec;50(12):1351-6
references.pmid: 10052848
references.citation: Antimicrob Agents Chemother. 2011 Sep;55(9):4204-10
references.pmid: 21670183
references.citation: PLoS Pathog. 2011 Sep;7(9):e1002229
references.pmid: 21931549
references.citation: J Vector Borne Dis. 2008 Jun;45(2):105-11
references.pmid: 18592839
references.citation: Clin Microbiol Infect. 2011 Oct;17(10):1478-83
references.pmid: 21933306
references.citation: Clin Microbiol Rev. 2006 Jan;19(1):111-26
references.pmid: 16418526
references.citation: Open Med Chem J. 2011;5:31-9
references.pmid: 21629509
references.citation: Lancet Infect Dis. 2005 Dec;5(12):763-74
references.pmid: 16310148
references.citation: J Biomed Biotechnol. 2010;2010:617521
references.pmid: 19888437
references.citation: Antimicrob Agents Chemother. 1993 Apr;37(4):859-63
references.pmid: 8494383
references.citation: PLoS Negl Trop Dis. 2012;6(5):e1657
references.pmid: 22629478
references.citation: Int J Antimicrob Agents. 2003 Oct;22(4):380-7
references.pmid: 14522101
references.citation: Antimicrob Agents Chemother. 2004 Aug;48(8):3033-42
references.pmid: 15273118
references.citation: PLoS Negl Trop Dis. 2010 May 04;4(5):e675
references.pmid: 20454559
references.citation: PLoS Negl Trop Dis. 2012;6(6):e1674
references.pmid: 22724029
references.citation: Int J Parasitol. 2009 Oct;39(12):1289-303
references.pmid: 19445946
references.citation: Nat Rev Microbiol. 2007 Nov;5(11):873-82
references.pmid: 17938629
references.citation: Antimicrob Agents Chemother. 2011 Apr;55(4):1777-80
references.pmid: 21220526
references.citation: Clin Infect Dis. 2009 Sep 15;49(6):914-8
references.pmid: 19663597
references.citation: Mol Biol Int. 2011;2011:571242
references.pmid: 22091408
references.citation: Antimicrob Agents Chemother. 2012 Feb;56(2):1031-41
references.pmid: 22123699
references.citation: N Engl J Med. 2002 Nov 28;347(22):1739-46
references.pmid: 12456849
references.citation: Indian J Med Res. 2006 Mar;123(3):311-30
references.pmid: 16778313
references.citation: Indian J Med Microbiol. 2012 Apr-Jun;30(2):227-9
references.pmid: 22664444
references.citation: BMJ. 1998 Apr 18;316(7139):1200-5
references.pmid: 9583927
references.citation: Br J Dermatol. 2011 Aug;165(2):411-4
references.pmid: 21561437
references.citation: Rev Soc Bras Med Trop. 1995 Jul-Sep;28(3):273-7
references.pmid: 7480924
references.citation: J Infect Dis. 1992 Mar;165(3):528-34
references.pmid: 1311351
references.citation: Lancet. 1992 Nov 21;340(8830):1256-7
references.pmid: 1359322
references.citation: Trans R Soc Trop Med Hyg. 2006 Jul;100(7):698-700
references.pmid: 16325873
references.citation: Trials. 2011 Jun 30;12:166
references.pmid: 21718522
references.citation: Lancet Infect Dis. 2013 Mar;13(3):251-9
references.pmid: 23427890
references.citation: Int J Parasitol. 2007 Aug;37(10):1053-62
references.pmid: 17548090
references.citation: Ther Clin Risk Manag. 2012;8:323-8
references.pmid: 22802694